TRACTION - AND VALIDATION
NASA, DOE, and USDA validated the efficacy of Aequor's chemicals for use in water treatments, ethanol production, and surface cleaners. The NIH and DOD selected Aequor for their prestigious accelerator programs to develop new drug candidates. Aequor's subsidiary in London, Aequor Ltd., won a Phase I EU Horizon 2020 grant in the BioMed category. Aequor is a member of several organizations including the Biotechnology Innovation Organization (BIO), Green Chemistry and Commerce Council (GC3), Antimicrobial Resistance Industry Association, various DOD consortia for biodefense, etc. and won the NASA iTech Award in the Life Support category. Aequor was selected by the U.S. government to represent American Innovation at the Global Entrepreneurship Summit 2019 in The Hague.
PRODUCT BENEFITS
Aequor's green, chemicals can replace costly, toxic and ineffective biocides used in thousands of agro-industrial and consumer products and processes.
They work rapidly and save time, manpower, and money, as well as reducing energy consumption and CO2 emissions.
Cynthia K. Burzell
Marilyn J. Bruno
Marilyn J. Bruno
Cynthia K. Burzell
Marilyn J. Bruno
Ph.D., J.D.
Ex-Economic Bureau of US Department of State
Founder & CEO
Cynthia K. Burzell
Cynthia K. Burzell
Cynthia K. Burzell
Cynthia K. Burzell
Cynthia K. Burzell
Ph.D.
Medical and Marine Microbiology
Founder & CSO
Anne Lamsa
Anne Lamsa
Anne Lamsa
Anne Lamsa
Anne Lamsa
Ph.D.
Senior Scientist
INVESTMENT OPPORTUNITY
The "Green chemical" sector grew from $11 Billion in 2015 to $89 Billion in 2018. Aequor will participate in this upward trend, reducing the toxic load on ecosystems and organisms and improving plant, animal and human health through the use of sustainable chemicals, while reducing energy consumption and carbon emission.